GSK and University of Oxford Experimental Medicine Collaboration
Program · Oxford, United Kingdom
Website: oahp.org.uk. £10m five-year GSK and University of Oxford collaboration on immune-mediated inflammatory diseases.
Recent activity confirmed, checked October 18, 2026.
In context
GSK and University of Oxford Experimental Medicine Collaboration is one of 46 programs in Oxford listed in the Innovative EcoSystems registry, and one of 188 across the United Kingdom.
The registry lists 444 innovation ecosystem organizations in Oxford in all.
Programs fund or deliver support for innovation and entrepreneurship, from grant schemes to training initiatives.
The United Kingdom scores 67.4 out of 100 on the IEPA (2024 edition), ranking 24 of 117 economies.
See the United Kingdom on the IEPA ↗
More programs in Oxford
- GSK-Oxford Cancer Immuno-Prevention Programme
Oxford - Centre of Excellence for Hybrid Thermal Propulsion Systems
Oxford - IF Oxford
Oxford - Generative Biology Doctoral Training Programme
Oxford - Correlates of Immunity-Artificial Intelligence (CoI-AI) programme
Oxford - Graduate Ellison Scholars programme
Oxford - Oxford-Max-Planck Doctoral Programme
Oxford - Equinox (Equitable Innovation Oxford)
Oxford
Elsewhere in Oxford
- Creative Destruction Lab - Oxford
Accelerator - James Cowper Kreston
Company - Perspectum Ltd. (United Kingdom)
Corporate R&D - Reuben College, Oxford
College or training provider - Oxfordshire Leaders Joint Committee
Government or public body - Manor Hospital
Health research - Bioinnovation Hub, Oxford Brookes University
Incubator - Wood Centre for Innovation
Innovation hub
More programs in the United Kingdom
- Kent and Medway Business Advisory Board
Maidstone - ImpactU
- Kent and Medway Growth Hub
Maidstone - Hampshire and the Solent Local Skills Improvement Plan
Hampshire-wide - Venturefest South
Southampton - Reading & Thames Valley Health Innovation Partnership
Reading - Diverse Sussex
Brighton and Hove - Fit For Offshore Renewables (F4OR) South Wales